Retin-A Gel contains tretinoin 0.025% w/w, also known as all-trans-retinoic acid, a topical retinoid derived from vitamin A. Tretinoin is a prescription dermatological medication indicated for the topical treatment of acne vulgaris, including acne characterized by comedones, papules, and other inflammatory lesions. This formulation is supplied as a 30g tube of 0.025% tretinoin gel.
Tretinoin works primarily by influencing epidermal cell growth and differentiation and normalizing the way skin cells are shed within the follicle. Acne can develop when dead skin cells and sebum accumulate inside hair follicles, contributing to the formation of microcomedones, blackheads, whiteheads, and inflammatory lesions. By increasing the turnover of follicular epithelial cells and reducing abnormal keratin buildup, tretinoin helps keep pores clearer and reduces the formation of new comedones.
Unlike treatments that primarily target acne-associated bacteria, tretinoin acts directly on the follicular keratinization process involved in pore blockage. Continued topical treatment can help reduce existing comedonal acne while limiting the development of new lesions, making topical retinoids an established component of acne management.
Tretinoin also influences epidermal renewal and skin structure, which explains its broader dermatological interest in areas such as uneven pigmentation, fine lines, and photoaged skin. However, Retin-A 0.025% Gel’s approved Canadian indication is acne vulgaris, and other cosmetic applications should be discussed with a healthcare professional.
This product provides:
- Active Ingredient: Tretinoin (all-trans-retinoic acid)
- Strength: 0.025% w/w
- Format: Topical Gel
- Quantity: 30g
- Drug Class: Topical Retinoid
- Primary Indication: Acne Vulgaris
Retin-A can cause dryness, redness, peeling, burning, or temporary skin irritation, particularly during the first weeks of treatment. Excessive application does not improve results faster and can increase irritation. Sensitive areas around the eyes, mouth, mucous membranes, and damaged or eczematous skin should be avoided.
Tretinoin-treated skin can also become more sensitive to sunlight and ultraviolet exposure. Appropriate sun protection and minimizing unnecessary UV exposure are important during treatment. Other potentially irritating topical products should be introduced cautiously, particularly products containing strong exfoliating, drying, or abrasive ingredients.
Retin-A 0.025% is listed by Health Canada as a prescription medication containing tretinoin and should be used according to the directions of a qualified healthcare professional.
